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Abstract
Background: LGR5 (Leucine-rich repeat-containing G-protein coupled receptor 5) is the most established marker for
intestinal stem cells. Mouse models show that LGR5+ cells are the cells of origin of intestinal cancer, and LGR5 expression is
elevated in human colorectal cancers, however very little is known about LGR5 function or its contribution to the stem cell
phenotype and to colorectal cancer.
Principal Findings: We have modulated the expression of LGR5 by RNAi (inhibitory RNAs) or overexpression in colorectal
cancer cell lines. Paradoxically, ablation of LGR5 induces increased invasion and anchorage-independent growth, and
enhances tumourigenicity in xenografts experiments. Conversely, overexpression of LGR5 augments cell adhesion, reduces
clonogenicity and attenuates tumourigenicity. Expression profiling revealed enhanced wnt signalling and upregulation of
EMT genes upon knockdown of LGR5, with opposite changes in LGR5 overexpressing cells. These findings suggest that
LGR5 is important in restricting stem cells to their niche, and that loss of LGR5 concomitant with activated wnt signalling
may contribute to the invasive phenotype of colorectal carcinomas.
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Introduction
The concept of cancer stem cells (CSCs: reviewed by [1]) arises
from the heterogeneity of most solid tumours and their resistance
to chemotherapeutic regimes: according to this concept, after
treatment a residual population of drug-resistant cancer stem cells
will survive and rapidly proliferate to re-establish the tumours ([2]).
The relative resistance to chemotherapeutic drug has been
attributed to dormancy or slow proliferation of CSCs, a
characteristic shared with normal stem cells (see for example
[3]). Support for the existence of human CSCs is the presence,
within the tumours, of cellular subsets expressing proteins usually
only found on stem cells and lost upon differentiation; these
proteins have been used to enrich for the putative CSCs in
different tumour types, and to prove that tumour cells enriched for
these markers gives rise to tumours with greater efficiency than the
unselected population [4]. Given the relevance of CSCs to
tumourigenesis and metastasis [5], [6], more effective tumour
therapies require a better knowledge of the characteristics of this
subset of cancer cells and of the factors, extrinsic and intrinsic,
which contribute to their ‘stemness’. Assessing the relevance and
physiological role of the ‘‘stem cell markers’’ to the stem cell
phenotype will substantially increase our understanding of CSCs
and should aid in devising selective therapies.
In the case of colorectal cancer stem cells (CCSC) at present the
best characterized ‘‘stem cell’’ markers are the surface antigens
CD133 [4], [7] CD166 [8], CD44 and CD24 ([9],[10] (Reviewed by
[11]). Intracellular markers of CCSCs include Musashi-1 ([12], [13]),
Bmi-1 [14] and ALDH [15] (reviewed in [16]. However the most
selective and promising marker of the stem cell in intestinal
epithelium and of the intestinal cancer stem cells is LGR5 [17]
(UNIPROT Accession # O75473; UNIGENE # Hs.658889; also
called GPR49). In normal intestine LGR5 expression is restricted to
the stem cell zone at the base of the crypt [18] and single cells from
the small intestine expressing LGR5 can generate structures
resembling intestinal crypts ‘in vitro’ [19], [20]. Most importantly,
Barker et al.[21] have shown inmouse models thatintestinal tumours
arise from LGR5 positive cells, suggesting it marks the intestinal
cancer stem cells. LGR5 is overexpressed in human colorectal
adenomas and carcinomas relative to normal mucosa [22]: thus
LGR5 overexpression is detected from the early stages of colorectal
tumourigenesis.LGR5isawnttargetgene [23],and the wnt pathway
is activated early in the progression of the majority of colorectal
cancers through truncations of APC (Adenomatous Polyposis Coli)
and, less frequently, mutations of b-catenin (reviewed by [24]). It is
unclear, however, whether LGR5 upregulation in colorectal cancer
cells contributes significantly to tumourigenesis through maintenance
of colorectal CSC, or is simply a reflection of activated wnt signalling,
with no direct functional role.
Little is known about LGR5 function in development and
carcinogenesis. LGR5 is an ‘orphan’ receptor belonging to the G-
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of intracellular signalling are at present unclear [26]. Knockout of
LGR5 in mice results in neonatal mortality associated with
craniofacial defects (ankyloglossia) [27]. A thorough study by
Garcia et al [28] of prenatal intestinal development in GPR49-
LacZ mutant mice (LGR5 null) shows that loss of LGR5 does not
affect proliferation or migration of intestinal cells. However the
authors noted a strong induction of Paneth cell differentiation in
LGR5 knockout embryos, and a molecular signature characteristic
of upregulated wnt signalling.
As LGR5 appears to be a marker of CCRCs, we have
investigated which parameters of cell growth and differentiation
are affected by modulation of LGR5 expression in colorectal
cancer cell lines. Due to the functional redundancy of many
signalling molecules and the strong feedback loops that maintain
homeostasis, these studies are difficult to interpret in animal
models, while low transfection efficiencies and restrictions on long-
term culture prevent these studies in human primary tumour
samples. To circumvent these difficulties we have used two
colorectal carcinoma cell lines, LIM1215 [29] and LIM 1899 [30]
as a model system. Our results show that LGR5 silencing and
overexpression have opposing effects on cell phenotype, including
anchorage-independent growth, migration and tumour formation
as xenografts in mice. Paradoxically, suppression of LGR5
expression enhances tumourigenesis and is linked to a more
mesenchymal phenotype. A study of the gene expression patterns
after modulation of LGR5 cellular levels by siRNA knockdown or
transgenic overexpression shows that loss of LGR5 upregulates
wnt response genes and key EMT pathway genes; conversely,
overexpression of LGR5 favours cell-cell adhesion. These results
highlight the importance of LGR5, not simply as marker of
colorectal tumour cells, but as a regulator of wnt responses, cell
motility and cell-cell adhesion.
Results
LGR5 is expressed in colorectal cell lines with b-catenin
mutations and upregulated by wnt stimulation in cells
with APC mutations
Colorectal tumours are characterized by mutations in wnt
pathway signalling components [31],[32],[33], principally APC
and b-catenin, leading to disregulated or cell-autonomous
responses to wnt. LGR5 is overexpressed in primary colorectal
tumours [34], [35]: overexpression could conceivably be due to
enrichment of ‘stem-like’ cells, to upregulation of the wnt
signalling pathway, and/or to wnt pathway-dependent mainte-
nance of ‘stemness’’. We utilized a panel of previously character-
ized human colorectal carcinoma cell lines [33] to compare LGR5
expression to the expression of another putative intestinal stem cell
marker, Musashi-1 (Msi-1) [36],[12], [37]. Cells expressing high
levels of LGR5 do not generally express high levels of Msi-1, and
vice versa (Fig. 1A). Interestingly, we detected elevated levels of
LGR5 mRNA only in cell lines carrying b-catenin mutations
(Figure 1A). The elevation of LGR5 in b-catenin mutant cells is
striking, suggesting that mutational activation of b-catenin is
responsible for overexpression of LGR5, while mutation of APC is
not sufficient to induce detectable LGR5 expression in these cell
lines. To test the wnt dependence of LGR5 expression, we
stimulated the cells with L-cell derived wnt3a, wnt5a or control
conditioned media. LGR5 and Musashi-1 mRNA levels were
tested in parallel by qRT-PCR 12 hrs after stimulation (Fig. 1B).
As expected, LGR5 expression levels are unaltered by wnt3a
stimulation in the b-catenin mutant cell line LIM1899 but
selectively upregulated by wnt3a in APC-mutant cell lines LIM
2537, LIM 2405 and Lim1863 (Fig. 1B, left panel). Wnt
stimulation did not affect the expression levels of Msi-1 in any of
the cell lines tested (Fig. 1B, right panel). Upregulation of LGR5
by canonical wnt signalling in responsive cell lines was confirmed
by immunostaining with a validated antibody to LGR5 (Fig. S1A).
In these experiments, maximal levels of LGR5 protein were
observed 48 hrs after stimulation of the cells with wnt3a, while
neither wnt 5a or L-cell conditioned medium induced LGR5
expression (Fig. S1B and data not shown). Thus elevated levels of
LGR5 in colorectal cancer cells are likely to be secondary to
activated canonical wnt signalling, and mutations in b-catenin
bypass the requirement for exogenous ligands. We have previously
shown that LIM cell lines with heterozygous APC mutations have
weakly activated wnt signalling resulting from autocrine produc-
tion of canonical wnts [33]: the lack of LGR5 overexpression in
these cells in the absence of exogenous wnt3a suggest a threshold
effect for LGR5 induction.
Modulation of LGR5 expression has profound effects on
clonogenicity and tumourigenesis
If overexpression of LGR5 in colorectal cancer cells is mediated
by hyper-activated wnt pathway, what role does LGR5 play in wnt
responses, and does expression of LGR5 contribute to the
maintenance of ‘‘cancer stemness’’? To address the functional
relevance of LGR5 expression in CRC cell lines, we reduced its
expression in cells carrying a b-catenin mutation (LIM1215 and
LIM1899) using inhibitory RNAs. We initially utilized lentiviral
transduction of shRNA (short hairpin RNA) to LGR5. As controls,
we used shRNAs directed to random sequences (non-target, NT)
or to Msi-1. Musashi-1 is expressed in immature intestinal cells
[12,37] and is overexpressed in colorectal tumours [35], but is not
a wnt-response gene (Fig. 1B). We used four separate shRNA
constructs for each target gene: all were effective, and subsequent
experiments were conducted using the most efficient shRNAs.
Transduced cells were bulk selected in puromycin for two weeks to
enrich for the shRNA-expressing cells, then switched to antibiotic-
free media for functional characterization. Knockdown efficiency
was monitored by qRT-PCR and cell proliferation was assayed
using MTT assays and colony formation in soft agar. Lentiviral
delivery of shRNA to LGR5 or to Musashi-1 was effective in both
cell lines and lead to a marked and specific reduction in expression
of the target genes (Fig. 2 A,B, B). The expression levels of the
related genes LGR6 and Msi-2 were unaffected (data not shown).
We confirmed loss of LGR5 protein after knockdown using
immunofluorescence (Fig. S2), as LGR5 antibodies are not suitable
for the detection of endogenous levels of this protein by Western
Blot.
Knockdown of either LGR5 or Msi-1 levels did not affect the
growth of cells as adherent monolayers (Fig. S3A), however loss of
LGR5 and Msi-1 had striking and opposing effects on the
clonogenicity of the cells in soft agar (Fig. 2C). Knockdown of
Musashi-1 lead to a reduction in the colony forming ability of both
LIM1215 and LIM1899 cells, consistent with the loss of
proliferation and tumour forming ability of the colorectal cell line
HCT116 after downregulation of Msi-1 as reported by Sureban
et al [13]. In contrast, loss of LGR5 caused a reproducible and
profound increase in the clonogenicity of both LIM1215 and
LIM1899 (Fig. 2 C,D). These effects on colony formation were
observed consistently in both cell lines and using two separate,
LGR5-specific shRNA constructs.
Selection of the cells in puromycin might have led to changes in
the expression of genes other than LGR5, contributing to this
surprising result. We repeated the knockdown experiments using
transient expression of Cy3-labelled siRNA (small hairpin RNA) to
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expression of the Cy3-labelled siRNA was monitored by
fluorescence microscopy. Transfection efficiency, assessed by
Cy3 expression using fluorescence microscopy, was .80% in
LIM1899, but ,20% in LIM1215; consequently subsequent
experiments were performed using LIM1899 cells.
Knockdown of LGR5 by siRNA was very efficient (.90%)
and specific (Fig. 3A). Importantly, shRNA and siRNA
knockdown of LGR5 had identical effects on the clonogenicity
of LIM1899, confirming that this phenotype is the result of
LGR5 downregulation and is not an artefact of the selection
process (Fig. 3B).
Figure 1. Expression of stem cell markers in CRC cell lines and selective induction of LGR5 by wnt 3a. A) Expression levels for LGR5 and
Msi-1 were determined by qRT-PCR as described in Methods. Results are presented as gene expression relative to the endogenous control HPRT
within each cell line. Cells have been grouped according to their b-catenin or APC mutational status. B) Cell lines carrying b-catenin mutation (LIM
1899) or APC mutations (LIM2537, LIM2405, LIM1863) were stimulated for 12 hrs with culture medium (no stimulus), with conditioned medium from
L-cells expressing wnt 3a or wnt 5a, or with untransfected L-cell conditioned medium (control CM). Expression of LGR5 (left panel) and Musashi-1
(right panel) was determined by qRT-PCR as described in Methods. For each cell line, bars represent expression level of stimulated relative to
unstimulated cells.
doi:10.1371/journal.pone.0022733.g001
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clonogenicity of colorectal cancer cell lines, we investigated
whether LGR5 overexpression would reduce the growth of these
cells in soft-agar by performing both transient and stable
overexpression of LGR5 in colorectal cell lines. We chose to use
the same cell lines for both silencing and overexpression of LGR5
in order to minimize non-LGR5 specific changes in cellular
parameters. While this strategy risks underestimating the effects of
LGR5 overexpression, it allows a direct comparison between
transfected cells and facilitates the interpretation of expression
profiling.
LIM1899 and LIM1215 cells were transfected with pTUNE
vector containing the human LGR5 sequence flanked by myc and
flag sequences. The efficiency of transfection for LIM1899 varied
in these experiments between 30 and 60% as assessed by
immunostaining of the cells with anti-flag antibodies, while
transfection efficiency was between 10–20% for LIM1215 cells:
hence subsequent experiments were carried out in LIM1899 cells.
Overexpression of flag-tagged LGR5 in transfected cells was
confirmed by qRT-PCR and by immunofluorescence using anti-
flag and anti-LGR5 antibodies (Fig. 4 A,B). Over-expressed LGR5
was present both in the cytosol and at the plasma membrane; with
accumulation in punctuate structures (Fig. 4A). This distribution is
similar to the distribution of endogenous LGR5 in colorectal
cancer cells after wnt stimulation (Fig. S2). The pTune system is
designed for IPTG- inducible expression of proteins, however high
levels of expression were present in the absence of IPTG, with only
a moderate increase after induction (Fig. 4 B). Overexpression of
LGR5 in LIM1899 resulted in a significant loss of colony-forming
ability in soft agar (Fig. 4C) without affecting proliferation under
adherent conditions (Fig. S3). Parallel transfection of the cells with
Cy3-siRNA to LGR5 caused the expected increase in colony
numbers in the same assay (Fig. 4C). Stable cell lines overex-
pressing LGR5 were generated by selection of the transfected cells
in neomycin: LGR5 expression in these cell lines, as assessed by
qRT-PCR and immunofluorescence, was increased significantly
(Fig. S4 A, B), and was inversely correlated with clonogenicity in
soft agar (Fig. S4 C,D). Thus LGR5 modulation has consistent and
specific effects on the clonogenicity of colorectal cancer cell lines.
Clonogenicity in semi-solid media of tumour cells often
correlates with their ability to form tumours in immunocompro-
mised mice. We used a xenograft model to test whether
modulation of LGR5 affects the tumourigenicity of LIM1899
cells. LIM1215 was not tested in this system as it is both poorly
tumourigenic as a xenograft and transfects with very low
efficiency. LIM1899 cells were expanded and transfected in bulk
with Cy3-siRNA to LGR5 or with pTune-LGR5. Transfected and
parental cells were expanded for two days, then harvested for
parallel determination of LGR5 expression by qRT-PCR,
clonogenicity ‘in vitro’ and tumour-forming capacity ‘in vivo’
Figure 3. Knockdown of LGR5 by siRNA. LIM1899 cells were transfected with vector expressing Cy3 (Cy3) or Cy3-siRNA to LGR5 (Cy3 siLGR5). A)
LGR5 expression by qRT-PCR in untransfected cells (parental) and cells transfected with Cy3 or Cy3-siRNA to LGR5. Plots represent LGR5 expression of
test samples relative to the parental (untransfected) cell line. B) LIM 1899 cells were plated in soft-agar two days after transfection at 56103 cells/ml
and cultured for 10 days. Colony numbers were assessed after staining with crystal violet using a dissecting microscope. Plots represent colony
number in test samples relative to the parental cells. The increase in colony numbers upon silencing of LGR5 is extremely significant (***=p,0.0001
by the unpaired t-test). For both panels data are mean and sd of triplicate samples, and are representative of at least 3 separate experiments.
doi:10.1371/journal.pone.0022733.g003
Figure 2. shRNA knockdown of LGR5 and Msi-1 have opposite effects on cell growth in soft agar. A) and B): LIM1215 (A) and LIM1899 (B)
cells were transduced with lentiviral particles containing shRNA to non target sequences (NT), to LGR5 (shLGR5) or to Musashi-1 (shMsi-1) and bulk
selected in puromycin. Expression of LGR5 (left panels) and Musashi-1 (right panels) was assessed by qRT-PCR two weeks after transduction. Data are
presented as gene expression relative to the parental cell lines. These results are representative of .5 separate experiments. C): Cells expressing
shRNAs (shLGR5, shMsi-1 and NT) and parental cells were grown in antibiotic-free medium for three days then tested for their ability to form colonies
in soft agar as described in Methods.. Data are presented as colony forming efficiency of test samples relative to control (untransfected) parental cells
and are the average and sd of three separate experiments. D): Representative images of colonies in soft-agar plates stained with crystal violet. Images
were acquired with a Nikon 90i with a DXM 1200C camera.
doi:10.1371/journal.pone.0022733.g002
LGR5 Modulates Wnt Responses and EMT
PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22733(Fig. 5). The proportion of transfected cells, monitored by
fluorescence microscopy for Cy3siRNA expression and immuno-
staining with anti-flag antibody for LGR5 overexpression, were
80% and 60%, respectively. The cells used for the xenografts had
the expected reduction or increase in LGR5mRNA (Fig. 5B):
suppression of LGR5 expression persisted for up to two weeks in
cells treated with siRNA, while overexpression of LGR5 had
returned to baseline by 14 days (Fig. 5C). The clonogenicity of the
cells used in xenografts was inversely proportional to the level of
expression of LGR5 (Fig. 5D). Cells expressing siRNA to LGR5
showed enhanced tumour formation; conversely, cells overex-
pressing LGR5 were less tumourigenic (Fig. 5A,B). The difference
in tumour size between the LGR5 knockdown and the parental
cells was highly significant (p,0.0001) at all time points, however
the growth of tumours overexpressing LGR5 differed significantly
from parental cells only for the first 10 days of the xenografts
experiment (Fig. 5A). The difference in the stability of expression
of the siRNA to LGR5 vs. the LGR5 construct (Fig. 5C) is
consistent with the long-term effects of LGR5 downregulation and
the more transient effects of LGR5 upregulation on the xenografts.
We observed very good correlation (R=0.996) between clono-
genicity in soft agar and tumourigenicity (Fig. 5D), confirming the
validity of the former as a substitute assay.
We analysed the subcutaneous tumours for LGR5 expression
using immunofluorescence. Representative images of the tumours
stained with heamatoxilin and eosin (A), or co-stained with LGR5
Figure 4. Overexpression of flag-tagged LGR5 and its effect on clonogenicity in LIM 1899 cells. LIM1899 cells were transfected with
pTune vector containing human LGR5 flanked by a flag sequence and analysed 3 days after transfection. A) Confocal microscopy: LIM 1899 cells
transfected with pTune/LGR5 were co-stained with anti-flag (M2) antibody followed by Alexa488 anti-mouse Ig (green), anti-LGR5 antibody
HPA012530 followed by Alexa 546 anti-rabbit Ig (red) and the nuclear stain DAPI. Shown is a merged image (all channels) and greyscale images of the
green and red channels, respectively. Confocal microscopy was performed as described in Methods. B) qRT-PCR: untransfected cells (parental) and
cells transfected with the LGR5 expression vector were cultured for three days with or without IPTG (100 mM). RNA extraction and qRT-PCR were
performed as described in Methods. The graph shows the level of expression of LGR5 in transfected relative to parental cells. Data are the mean +/
2sd of triplicate samples, and are representative of .3 separate experiments. C) Clonogenic assay: untransfected cells and cells transfected with
pTune/LGR5 or with Cy3-siRNA to LGR5 were seeded in soft-agar plates at 56103 cells/plate as described in Methods. IPTG (100 mM). was added to
triplicate plates for parental and LGR5-expressing cells only. Plates were incubated for 10 days then stained with crystal violet and colonies counted
with a dissecting microscope. The graph shows means and standard deviation of three separate experiments, each normalized to the colony
numbers for parental cells. The difference between parental and transfected cells is highly signficant (**=p,0.005 and ***=p,0.001 for the two
culture conditions).
doi:10.1371/journal.pone.0022733.g004
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22733Figure 5. Xenograft tumour growth is affected by the levels of LGR5. LIM1899 cells were mock transfected (no vector), transfected with
Cy3LGR5 or with pTune/LGR5. Cells were expanded for two doublings (48 hrs) after transfection, then collected for inoculation in nude mice,
determination of growth in soft agar and measurement of LGR5 expression by qRT-PCR as described in Methods. A) Left panel: xenografts tumour
growth curves, right panel: tumour mass at day18. The growth of subcutaneous tumours was measured three times weekly using callipers, and
volume determined by the formula V=1/2 (length6width
2). At the end of the experiment (day 18) tumours were dissected and weighed. Data are
averages and standard errors for each group (16 tumours/group). There was no statistical difference between parental and pTune Lgr5 tumour mass,
however the difference between parental and siLGR5 tumours is significant (***=p,0.001). B) A sample of cells used for xenograft injection was
LGR5 Modulates Wnt Responses and EMT
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Morphologically, all tumours consisted of well defined glands, and
could be classified as moderately differentiated adenocarcinomas
(Fig. 6A). Tumours derived from siLGR5 LIM1899 tended to
have a more disordered morphology, reflected in the subtle but
significant difference in the number of well-formed glands per field
between parental tumours (26+/23 n=16) and siLGR5 tumours
(15+/22 n=16; p=0.0014). The number of glands per field was
increased in tumours overexpressing LGR5 (31+/22, n=16)
however the difference from the parental tumours was not
statistically significant. In all tumour samples LGR5 staining was
most prominent in the glands, particularly towards the gland
lumen, and was weaker in the more amorphous areas of the
tumour (Fig. 6B). Staining for LGR5 was specific, as no signal was
detected in samples incubated with normal rabbit serum (Fig. 6C).
LGR5 immunoreactivity was marginally elevated in tumours
derived from LIM1899 cells transfected with pTune LGR5, but
not in all areas of the tumours. LGR5 staining was decreased, but
not totally absent, in tumours derived from LIM1899 cells
transfected with siLGR5. In these samples, LGR5 expression
appeared restricted to the glandular structures (Fig. 6B).
Cell-cell adhesion and migration are regulated by LGR5
levels
LGR5 levels have profound effects on the anchorage indepen-
dent proliferation of colorectal cancer cells ‘in vitro’ and ‘in vivo’;
however how LGR5 modulates anchorage-independent growth is
unclear. We observed that LIM1899 cells overexpressing LGR5
tend to grow in ‘colonies’ with tight cell-to-cell contacts, while
LIM1215 and LIM1899 cells with reduced LGR5 are more diffuse
on the plastic surface (not shown). The opposite phenotypes
observed after knockdown or overexpression of LGR5, and their
consistency in transient and stable expression systems, indicate that
this phenomenon is directly correlated to LGR5 levels. Thus
LGR5 may modulate the balance between cell-cell and cell-
substrate adhesion. To characterize cell-matrix and cell-cell
interactions we cultured cells as spheroids in hanging drops [38]
and performed both wound assays and motility assays to measure
the migration potential of the cells. Hanging drops assays measure
the proliferative potential of the cells in the absence of cell-matrix
interactions; wound assays assess the rate of movement of a cell
monolayer, and the motility assay measures the rate of migration
of the cells through the ECM in filter pores.
Parental LIM1899 cells, or LIM1899 cells transfected with
empty vectors, grow in hanging drops as aggregates with dense
centres (Fig. 7A). In parallel cultures, spheroids of cells with
reduced levels of LGR5 (siLGR5) are surrounded by a halo of
loosely-associated cells and are easily disrupted, while cells
expressing high levels of LGR5 (M2LGR5), either transiently or
stably, pack into compact spheroids resistant to mechanical
disruption (Fig. 7A and data not shown). The difference in cell
density is reflected in the volume of the spheroids relative to their
cellularity: while spheroids from different cell lines contain similar
number of cells (Fig. 7A, right hand graph), the difference in
volume between siLGR5 spheroids and spheroids overexpressing
LGR5 (Fig. 7A, left hand graph) is significant (p=0.001) reflecting
a tighter packing of the cells in M2LGR5.
In wound repair assays LGR5 overexpressing cells have a
reduced ability to repopulate the scratch wound compared to the
parental cells (Fig. 7B), and accumulate at the edge of the wound
forming a densely packed ridge of viable cells (Fig. 7B, larger
magnification). Both assays confirm the original observation that
LGR5 overexpression favours cell-to-cell adhesion. Transwell
assays were used to monitor the migration ability of cells with
different levels of LGR5. Cells were seeded in Transwell filters and
incubated for three days, before switching the upper filter contents
to serum-free medium to encourage migration. Under these
conditions, cells with reduced levels of LGR5 migrated to the
underside of the filters to a much greater extent than untransfected
cells, while cells overexpressing LGR5 had significantly reduced
migration (Fig. 7C). These differences in migrating cell numbers
were highly significant: p=0.002 for siLGR5, p=0.03 and
p=0.001 for transient (LGR5-Tr) and stable (LGR5-St) over-
expressors, respectively. Consistently, the reduction in motility
displayed by LGR5 overexpressing cells was proportional to the
level of LGR5 expression.
To understand the changes in adhesion and motility, we used
confocal fluorescence microscopy to monitor the localization and
expression of the adherens junction proteins E-cadherin, b-catenin
and Zo-1 in matched samples of parental, LGR5 knockdown or
LGR5 overexpressing LIM1899 cells (Fig. 8). Fixed cells were
incubated with the appropriate antibodies and fluorescent
secondary antibodies, and co-stained with rhodamine-phalloidin
to visualize actin. Neither the levels nor distribution of E-cadherin
changed significantly with up-or down-regulation of LGR5
(Fig. 8A), however there was a consistent recruitment of b-catenin
to the cell junctions in LIM1899 overexpressing LGR5 (Fig. 8B).
This was surprising as the LIM1899 cell line carries an activating
b-catenin mutation resulting in a predominantly cytosolic b-
catenin, with some weak association to the membranes but rarely
seen at the cell-cell junctions; this distribution is insensitive to wnt
signalling stimulation or inhibition [33]. The tight-junction
molecule Zo-1 was also increased at the cell-cell contacts in
LIM1899 cells overexpressing LGR5 (Fig. 8C). The relative
amounts of these proteins in cells under- or over-expressing LGR5
were also assessed by immunoblotting (Fig. S5 A, B), confirming
little change in total b-catenin levels, marginal increase in E-
cadherin (albeit not statistically significant), and significant
increase of Zo-1 (Fig. S5B). Overall, these results are consistent
with an enhancement of cell-cell adhesion in cells overexpressing
LGR5.
Given the effects of LGR5 modulation on cell migration, we
hypothesized that LGR5 levels might affect, directly or indirectly,
the expression or localization of adhesion molecules. CD44,
CD133 and CD166 are adhesion molecules expressed on intestinal
stem cells and colorectal cancer stem cells [8,39,40] and therefore
can be expected to have overlapping expression patterns to LGR5.
As these molecules have been used extensively as stem cell
markers, we also wanted to assess whether changes in LGR5
expression resulted in altered patterns of expression for these
markers. CD133 is not expressed on LIM1899, as assessed by flow
tested by qRT-PCR for LGR5 expression. Data were analysed in ABI 7300 (DDCt study), and are presented as LGR5 expression relative to the parental
cells. Data are presented as means and standard errors. C) Time course of transgene expression in cultured LIM 1899. The expression of LGR5 in cells
transfected with siLGR5 or pTune LGR5 was followed over a period of two weeks by qRT-PCR. Levels of LGR5 expression are presented relative to
vector control for each of the time points. D) A sample of cells used for the xenograft experiment was cultured in soft-agar plates at 5610
3 cells/plate
to determine cloning efficiency. Plates were incubated for 10 days, then stained with crystal violet and colony numbers determined by light
microscopy. ***=p,0.001. E) Correlation between tumour mass (graph A) and cloning efficiency (graph D).
doi:10.1371/journal.pone.0022733.g005
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high levels. Only CD44 surface expression is weakly enhanced by
upregulation of LGR5 in these cells (Fig. S6 B), but there is no
appreciable change in total cellular CD44 as assessed by
immunoblotting (Fig. S5). Confocal microscopy revealed that the
cell surface distribution of CD44 is subtly altered in LGR5
knockdown cells. In parental LIM1899 cells and in cells
overexpressing LGR5, CD44 associates with actin rings as assessed
by morphology and colocalization with actin (Fig. 9 A,B). When
LGR5 expression is reduced or abolished by inhibitory RNAs,
Figure 6. Morphology and LGR5 reactivity of xenografts tumours. A) Haematoxilin and eosin staining of frozen sections from representative
tumours generated from parental LIM1899, LIM1899 transfected with siRNA to LGR5 or LIM1899 transfected with pTune-LGR5 construct. Brightfield
images were acquired on a Nikon 90i microscope with a 206lens. B) Confocal images of frozen sections stained with antibodies to b-catenin (red),
LGR5 (green) or the DNA stain DAPI (blue). All images are Z-stacks of confocal sections. For each set, the upper panel shows the three combined
stains, the middle panel LGR5 (greyscale), and the bottom panel b-catenin (greyscale). Images were obtained on a Nikon C1 confocal microscope with
a6 0 6oil lens. C) Specificity control for LGR5 staining: frozen sections were stained with antibody to b-catenin and normal rabbit serum, followed by
Alexa 488 anti-rabbit Ig (green) and Alexa 546 anti-mouse Ig (red) and the nuclear stain DAPI (blue). The green channel (NRS) and red channel (b-
catenin) are shown separately in greyscale. Images were obtained as in B).
doi:10.1371/journal.pone.0022733.g006
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missing selectively from the focal actin rings (Fig. 9 A,B). This
phenomenon was observed consistently with knockdown of LGR5,
either by siRNA or shRNA, in both Lim1899 and LIM1215 cells
(Fig. S7). The distribution of CD44 in LIM 1899 cells
overexpressing LGR5 was unaltered. The F-actin circular
structures we observe closely resemble the CD44-rich podosome
rosettes described in the literature [41], [42]. These structures
contain MMPs and are sites of collagen-directed matrix degrada-
tion [43]. It is likely that the loss of CD44 reactivity from these sites
reflect localized CD-44 shedding, which is dependent on MMPs
and promotes cancer cell migration and invasion [44]. While a
detailed analysis of these ‘podosome-like’’ structures is beyond the
scope of this paper, we have evidence of increased expression of
the mRNA for EMT molecules, such as collagen and MMPs,
when the levels of LGR5 are reduced (see next section). These
results are consistent with the hypothesis that collagen and MMP-
mediated CD44 shedding is responsible for the observed selective
loss of CD44 reactivity from F-actin-rich structures when LGR5
levels decrease.
Expression profiling of cells with altered LGR5 levels
There is no known role for LGR5 in any well-defined
biochemical pathway or biological process, impeding a direct
assessment of changes driven by altered LGR5 levels. To assess the
pathways affected by LGR5 we performed expression profiling
using pathway-directed arrays. Given the important role of LGR5-
expressing cells in the intestine, we concentrated on three
pathways which are of paramount importance for intestinal
homeostasis and carcinogenesis, wnt, notch and EMT, using
pathway-specific PCR arrays. Expression patterns of pathway-
specific genes in LIM1899 and LIM 1215 cells after knockdown of
LGR5 by RNAi, and in LIM 1899 cells after overexpression of
LGR5, were compared to those of parental cell lines either
untransfected or transfected with empty vectors. To maximize the
robustness of the analysis, even at the cost of significance levels, we
analysed both stable and transient transfectants as replicates.
Altered gene expression was considered specific to LGR5
modulation only if up-or down-regulation was higher than 2-fold
relative to the control cells and these changes showed opposite
trends in the LGR5 knockdown and LGR5 overexpressing cells.
Genes which changed in similar way in both sets were discarded
from the analysis. Tables 1, 2 and 3 list, in alphabetical order, the
genes specifically affected by LGR5 modulation in the Wnt, Notch
and EMT pathways, respectively. Many genes were differentially
expressed between control and LGR5 up- or down-regulated cells,
but were not significantly altered in the other experimental set:
these genes are not included in Tables 1, 2, 3. Our analysis may
thus be biased against genes already maximally regulated by the
endogenous LGR5 levels. Tables 1, 2, 3 report the results for the
LIM1899 cell lines, since we had both knockdown and
overexpression samples for this cell line; the genes affected
similarly by LGR5 knockdown in LIM1215 are indicated by
asterisks. A full report of the analysis can be viewed in Tables S1,
S2, S3, S4, S5, S6 and Figures S8, S9, S10. Overall, the wnt
pathway analysis (Table 1) strongly supports the concept of an
increase in canonical wnt signalling upon knockdown of LGR5:
WISP1, Wnt5a, Fzd 7 and FGF4 have been reported to be
upregulated following wnt3a stimulation in epithelial cells [45,46]
[47,48], while Lef-1 [49] TCF7, TLE2 have been shown to be
downregulated in response to canonical wnt signalling. Further-
more, the b-catenin/Tcf inhibitors CtBP and CTNNBIP1 [50] are
downregulated after LGR5 silencing and upregulated upon LGR5
overexpression. The expression of only a few genes in the Notch
pathway was altered after modulation of LGR5 (Table 2), and
most are not restricted to the Notch signalling pathway (Fos,
FosL1, Keratin1 and MMP7) or are of unknown significance in
epithelial cells (e.g. SH2D1A and PTCRA). Notch2 and
Notch2NL are massively downregulated after LGR5 silencing,
albeit with low significance value (Table 2). As these genes are not
upregulated with LGR5 overexpression in lIM1899 cells, the
relevance of these findings is unclear. EMT genes are by far the
most affected by LGR5 overexpression or knockdown, with
selectively altered expression in 28 of the 84 genes in the array
(Table 3). Suppression of LGR5 leads to strong upregulation of
mesenchymal genes and of genes positively regulating EMT; these
same genes are markedly downregulated upon LGR5 overexpres-
sion (note however that most of these changes have p.0.1).
Particularly striking is the enhanced expression of extracellular
matrix proteins and of matrix-metalloproteases. It must be
stressed, however, that E-cadherin is not reduced and Vimentin
is not upregulated upon knockdown of LGR5; hence the picture
that emerges is of partial induction of EMT by loss of LGR5,
which correlates very well with the morphological and functional
observations described above (Fig. 7 and 8). This EMT-like
program could either be directly mediated by LGR5, or result
from enhanced wnt signalling, as many of the genes upregulated
by LGR5 silencing and linked to EMT are also upregulated
following canonical wnt activation [51,52] [53,54,55,56,57]. These
wnt responsive genes have been marked by a bullet in Tables 2
and 3. Wnt5a, which is significantly overexpressed after knock-
down of LGR5, is also strongly linked to EMT: [58,59] and may
contribute significantly to the observed phenotypes.
Discussion
The data presented here support the view that LGR5 is a wnt
response gene and its expression is induced and/or maintained
Figure 7. Effects of LGR5 modulation on cell-cell adhesion and migration. Lim1899 cells were transfected with vector controls (Cy3V and
pTuneV), with Cy3- siLGR5 or with pTune/LGR5. Parental, transiently transfected cells (Tr) or stably transfected cell lines (St) were cultured under the
following conditions: A) Cells were seeded in 30 ml droplets on a plastic surface, and the plate inverted to create hanging drops as described in
Methods. Images were taken after 8 days by re-inverting the plastic support and imaging in bright field with a Nikon 90i microscope and a 106lens.
Digital images were acquired with a Photometrics CoolSnap digital camera. Spheroid volumes (left-hand graph) were calculated from these images
using the modified ellipsoid formula. Spheroid sizes differed significantly between siLGR5 or M2LGR5 transfected cells and their counterparts
transfected with empty vector (p=0.0312 and p=0.321, respectively, by the unpaired t-test). The cellularity of the spheroids (right hand graph) was
assessed as described in Methods. In both graphs data represent the mean and standard deviation of 10 individual spheroids per cell line. B) Parental
cells and cells stably transfected with pTune/LGR5 (clones 6-1) were plated at high density in 24-well plates. Wounds were scratched in the adherent
monolyers and the wells were imaged every two days with a Nikon90i microscope using a 106lens (upper panels). The photomicrograph on lower
right shows a higher magnification of LGR5 6-1 wound at day 6 (206lens). Insert: Rate of wound closure over 96 hr. C) Cells were seeded in Transwell
inserts (8 mm pore size) and cultured for 4 days. Filters were fixed and stained with May-Grumwald/Giemsa. Cells on the upper side of the filters were
removed, and filters mounted on glass slides. Cells present on the underside of the filters (migrating cells) were counted by light microscopy as
described in Methods. The graph presents average and sd of three separate samples for each cell type. Tr and St denote transient and stable LGR5
transfectants. Significance levels were determined by the unpaired t-test. ***=p,0.001; **=p,0.005.
doi:10.1371/journal.pone.0022733.g007
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LGR5 (siLGR5) or pTune/LGR5 (LGR5) were grown in chamber slides and prepared for immunofluorescence as described in Methods. Slides were
stained with antibodies to E-cadherin (A), b-catenin (B) or Zo-1 (C) followed by Alexa 488 anti-mouse Ig (green channel in all samples). Cells were
counterstained with rhodamin-phalloidin (red channel) and the nuclear stain DAPI (blue channel). Images are Z-stacks of sequential confocal images.
For each antibody, the top panel shows the merged channels and the bottom panel the green channel only (grey scale).
doi:10.1371/journal.pone.0022733.g008
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investigation of the functional significance of LGR5 expression
in the context of colorectal cancer cell lines show that, rather than
contributing to the tumour phenotype, LGR5 antagonizes many
of the accepted characteristics of tumour cells such as anchorage-
independent growth, loss of cell-cell adhesion, enhanced migration
and a switch from the epithelial to a more mesenchymal
phenotype. In this cellular context, our observations that LGR5
suppresses responses to wnt signalling and antagonizes EMT are
unexpected and appear paradoxical, but have significant implica-
tions for intestinal cell biology. While LGR5 may well mark the
colorectal cancer stem cells, our data suggest that LGR5 is not
functionally required for tumour expansion but may instead play a
role in stem cell localization and restriction to a self-renewing
niche.
Our results are consistent with a model where expression of
LGR5 occurs with sustained levels of activation of the canonical
wnt pathway. High expression levels of LGR5 occur only in cells
with b-catenin mutations, not in cell lines with heterozygous APC
mutation, unless exposed to extracellular wnt. While there is
evidence of autocrine wnt signalling in these APC mutant cell lines
[33] it may be insufficient to upregulate LGR5, or other factors
may inhibit the upregulation of LGR5. In murine intestine, LGR5
expression is restricted to the base of the crypt, coincident with wnt
signalling from the adjacent Paneth cells [20]. Interestingly, in
neonatal mice loss of LGR5 in this compartment leads to
premature differentiation of Paneth cells, suggesting reciprocal
control between LGR5 positive stem cells and Paneth cells [28].
The maintenance of stemness, as opposed to differentiation,
appears to be dependent on sustained wnt stimulation and on
Figure 9. Distribution of CD44 in cells with altered levels of LGR5. Lim 1899 cells expressing siRNA to LGR5 (siLGR5) or the pTune/LGR5
construct (LGR5) were seeded on chamber slides, fixed and stained with rhodamine-phalloidin (red) or anti-CD44 followed by Alexa 488 anti-rat
(green). Nuclei were stained with DAPI (blue). A): typical patterns of CD44 localization in the different cells. B) micrographs selected to show the focal
actin rings and their coincidence (vector, LGR5) or lack of coincidence (siLGR5) with CD44. The lower panels show enlarged areas of the micrograph,
highlighting the actin structures associated with CD44. In these panels actin staining and CD44 staining are shown separately in greyscale.
doi:10.1371/journal.pone.0022733.g009
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form organoids with crypt-villus architecture, but exposure of
LGR5+ cells to exogenous wnt, or loss of APC, causes loss of
differentiation and acquisition of a proliferative progenitor
phenotype [20]: thus the ‘right’ amount of wnt signalling is
required for differentiation. Barker et al, [21] have elegantly
shown that, upon truncation of APC, cancer arises solely from the
LGR5+ stem cells, but the transformed cells in the transit-
amplifying compartment loose LGR5 expression while retaining
high expression of b-catenin, as detected by IHC, and hence wnt
signal activation, suggesting modulation of expression by other
factors. In human cancer, overexpression of LGR5 has been noted
in up to 90% of hepatocellular carcinomas with b-catenin
mutations [61] and in a large proportion of colorectal carcinomas
[34,35,60], where APC mutations and hence dysregulated wnt
signalling are preponderant. Thus the elevated expression of
LGR5 in colorectal cancer is likely to be secondary to dysregulated
wnt signalling.
LGR5 as a negative regulator of canonical wnt signalling
and positive regulator of cell adhesion
Ablation of LGR5 in colorectal cancer cell lines results in a gene
expression pattern consistent with increased canonical wnt
signalling. Overexpression of LGR5 has the reverse effect. This
observation, which is consistent with the ‘in vivo’ data presented
by Garcia et al. showing that depletion of LGR5 causes persistent
wnt signalling after it is normally switched off in the intestine [28],
positions LGR5 as a negative regulator of canonical wnt pathways.
Since LGR5 is a wnt-response gene, it is possible that we are
observing a negative feedback loop where LGR5 expression keeps
in check over-activation of canonical wnt signalling. Given the
strong upregulation of wnt5a upon reduction in LGR5 levels, it is
also likely that presence of LGR5 suppresses non-canonical wnt
signalling. Interestingly, in our experiments many of the wnt
response genes modulated by LGR5 expression are linked to
EMT, e.g. collagens, fibronectin, MMPs, wnt5a and FGF4. These
changes in expression pattern are associated with alterations in
anchorage-independent proliferation, in invasion, migration, cell
adhesion, tumourigenicity and tumour morphology with opposing
phenotypes of LGR5 knockdown and LGR5 overexpression.
Although our results show a switch of the cell lines to a more
mesenchymal phenotype upon removal of LGR5, this transition
does not have all the hallmarks of classical EMT: E-cadherin and
Table 1. Changes in wnt pathway gene expression upon modulation of LGR5 in LIM1899 cells.
Gene
Fold change
LGR5 silencing p value
Fold change
LGR5 overexpression p value
WISP1* 8.74 0.03 21.60 0.57
Wnt 5a* 7.38 0.004 23.53 0.04
Casein Kinase 1c* 4.05 0.04 21.21 0.84
FGF4* 3.41 NA 26.33 NA
Axin 1 2.26 0.07 22.43 0.10
Frizzled 7* 2.02 0.004 22.55 0.39
Lef -1* 24.39 0.03 1.76 0.05
FRAT 1 23.20 0.03 2.28 0.13
DIXDC1 22.82 0.11 3.14 0.016
DAAM 1 22.52 0.11 2.00 0.19
TLE2* 22.38 0.02 1.89 0.21
Tcf 7 * 22.25 0.25 2.01 0.18
CTNNBIP1 22.16 0.05 3.29 0.01
Kremen 1* 22.24 0.02 1.55 0.15
CtBP1 22.05 0.04 1.45 0.15
CtBP2 * 22.52 0.05 2.16 0.08
Expression levels of wnt pathway genes were analysed in three independent samples for each of parental cells, cells with LGR knockdown and cells with LGR5
overexpression using SABioscience pathway arrays. Data are presented as fold-change relative to the parental cells. Data were analysed as described in Methods using
the SABioscience analysis program. Only genes with at least 2-fold change in either sample set, and for which there are significant differences between the two sample
sets, are reported.
*the same trend in gene expression was observed in LIM1215 after knockdown of LGR5.
doi:10.1371/journal.pone.0022733.t001
Table 2. Changes in Notch pathway gene expression with
modulation of LGR5 in LIM1899 cells.
Gene
Fold change
LGR5 silencing p value
Fold change
LGR5
overexpression p value
WISP 1 6.01 0.07 22.78 0.94
SH2D1a 5.94 0.004 21.90 0.83
N MMP7 5.35 0.10 22.15 0.35
N Keratin 1 4.93 0.58 23.95 0.31
PTCRa 4.73 0.52 22.14 0.34
Fos 2.78 0.94 23.03 0.038
Notch 2 221.8 0.13 1.27 0.91
Notch2NL 215.74 0.20 1.55 0.76
Ndenotes genes reported in the literature to be affected by activation of
canonical wnt signalling.
doi:10.1371/journal.pone.0022733.t002
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cadherin is elevated, and there is strong upregulation of EMT
‘mastermind’ genes ZEB, SNAIL and TWIST. Our data lead to
the hypothesis that LGR5 expression in intestinal stem cells in the
context of activated wnt signalling serves to restrict the stem cells
to their niche, thus preventing inappropriate migration while
maintaining selective aspects of wnt-driven anti-differentiation
program. It is interesting, in this context, that most cell-surface
markers of intestinal stem cells are adhesion molecules. This view
accords with the statement of van den Brink and Offerhaus [62] in
a recent review: ‘‘Appropriate inhibition of canonical WNT
signalling not only acts to restrict the precursor-cell compartment
to the precursor-cell niche within a single colonic crypt but also
functions as an important brake on lateral stem-cell expansion
through crypt fission’’.
Implications for colorectal carcinogenesis
The expression of LGR5 in intestinal stem cells, its dependence
on activated wnt signalling, and its link to cell invasiveness position
LGR5 as a potential player in the transition from adenoma to
invasive carcinoma. In one study [60], similar positivity for b-
catenin and LGR5 (28% vs. 27%) was observed in adenomas, but
not in carcinomas (54% positive for LGR5 vs. 81% positive for b-
catenin), suggesting that in carcinomas the expression of LGR5
may become disconnected from canonical wnt signalling, or that
excess stimulation of wnt signalling may lead to loss of LGR5.
Since LGR5 suppresses wnt signalling and reduces EMT,
expression of LGR5 might be expected to be reduced during
specific stages of colorectal carcinogenesis, particularly at the
invasive front of the tumours. Two recent reports [63,64] support
a bi-modal regulation of LGR5 expression by wnt signalling:
induction of LGR5 at medium levels of wnt activation but loss of
expression with higher levels of wnt activation. Comparing two
genetic mouse models of intestinal carcinogenesis, Lewis et al. [64]
show highest LGR5 expression in tumours from APC(1322T) mice
compared with APC(min) mice, with inverse correlation to b-
catenin localization and the expression of wnt response genes,
suggesting that LGR5 expression is stimulated within a relatively
narrow range of wnt activation.[64]. In a different experimental
system (endometrial cancer model) Sun et al [63] demonstrate that
Table 3. Changes in EMT pathway gene expression upon modulation of LGR5 in LIM1899 cells.
Gene/Protein
Fold change
LGR5 silencing p value
Fold change
LGR5 overexpression p value
Collagen 1a 6.721 0.17 25.03 0.29
Collagen 3a 6.59 0.16 21.64 0.29
TFPI2 13.1 .14 22.60 0.56
SPP1 12.59 0.13 22.28 0.6
MITF 10.43 0.13 21.65 0.72
FOXC2 10.38 0.07 22.85 0.45
ESR 1 10.18 0.16 21.91 0.64
N-cadherin 9.50 0.16 22.64 0.59
N Fibronectin 1 7.38 0.16 21.56 0.74
ZEB 1 5 0.10 23.45 0.16
ZEB 2 7.17 0.10 22.54 0.46
GNG 11 6.8 0.24 22.65 0.58
N MMP2 3.66 0.09 25.67 0.16
N MMP3 6.43 0.02 25.09 0.12
N MMP9 3.40 0.03 27.91 0.04
N KRT 14 6.45 0.13 24.33 0.17
N KRT 7 3.46 0.08 21.31 0.79
N SNAI 2 5.31 0.08 21.13 0.09
N SNAI 3 2.13 0.30 21.38 0.66
PDGFRb 5.30 0.11 22.84 0.33
GSC 5.03 0.27 21.37 0.85
MAP1b 4.63 0.20 23.63 0.40
Caldesmon 1 4.32 0.16 22.81 0.22
N Twist-1 4.25 0.28 24.97 0.28
SPARC 4.11 0.09 27.02 0.02
SOX 10 2.43 0.09 23.74 0.67
STEAP 1 2.43 0.14 21.75 0.3
N Versican 2.31 0.45 24.14 0.30
Ndenotes genes which are reported in the literature to be upregulated following activation of canonical wnt signalling.
doi:10.1371/journal.pone.0022733.t003
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reduce the expression of LGR5 in the uterus. We have observed a
similar phenomenon in colorectal carcinoma cell lines expressing
heterozygous APC mutations, where exposure to increasing
amounts of wnt3a leads to a dose-dependent increase of LGR5
RNA in the range of 20–70 ng/ml, but no significant increase in
LGR5 is detected when wnt3a is used at 200 ng/ml. (Fig. S11) We
propose that these findings have implications for the role of LGR5
in colorectal cancer progression: induction of wnt activity by APC
mutation or b-catenin mutation would maintain LGR5 expression
outside the stem cell niche, however overstimulation of wnt
signalling at the invasive front of a tumour (where there is loss of E-
cadherin and b-catenin is reported to be strongly nuclear: [65])
would be expected to reduce LGR5 expression, thus facilitating
wnt-stimulated EMT and favouring invasiveness.
Thus the transition from adenoma to carcinoma may involve
selective loss of LGR5 in areas of wnt hyperactivation,
contributing to EMT and invasiveness. This hypothesis needs to
be directly investigated by co-staining a large set of primary
colorectal cancer specimens, including the invasive front, for
LGR5, b-catenin, wnt pathway target proteins and markers of cell
adhesion or EMT.
Materials and Methods
Reagents and antibodies
L-cells and L-cells expressing wnt 3a or wnt 5a were a kind gift
from Dr Hong Zhou, ANZAC rResearch Institute, University of
Sidney (ATCC # CRL-2648, CRL-2647 and CRL-2814
respectively).The ability of medium conditioned by cells expressing
wnt3a to activate the canonical wnt signalling pathway was
confirmed in b-catenin stabilization assays. Briefly, L-cells were
exposed to control L-cell conditioned medium or wnt3a
conditioned medium (each at 30% v/v) for 6 hr, then lysed in
SDS sample buffer for SDS-PAGE of total proteins. The gels were
transferred to nitrocellulose and probed with anti-b-catenin
antibody. Increase in the level of b-catenin upon incubation with
wnt3a reflects activation of canonical signalling.
Antibodies used in this study were: anti-LGR5 N-terminal
region Sigma Prestige HPA012530 (Sigma, St.Louis, MO); anti-
LGR5 central region, AP2745f (Abgent, SanDiego, CA); anti E-
cadherin mouse monoclonal antibody #610182 (BD Transduc-
tion Laboratories, San Diego CA); anti b-catenin mouse
monoclonal antibody #19920/610153 (BD Transduction Labo-
ratories, San Diego CA); anti-CD44 rat monoclonal antibody
#103002 (BioLegend, San Diego, CA) and AP00142PU-N (Novus
Biologicals, Littleton, CO); anti flag antibody M2 (Sigma, St Louis,
MO); anti ZO-1 antibody #61096 (BD Transduction Laborato-
ries, San Diego CA). Secondary antibodies were anti-mouse Ig
Alexa488,, anti-rat Ig Alexa488 and anti-rabbit Ig Alexa488, all
from Invitrogen Molecular Probes (Eugene, OR); anti-mouseIg,
and anti rabbit Ig IRDye800 and IRDye 700 were obtained from
Li-Cor (Lincoln, Nebraska).
Cell lines
LIM1899, Lim1215, LIM2537 and Lim1863 human colorectal
carcinoma cell lines (CellBank, Sidney, Australia) were used in this
study. Cells were routinely passaged in RPMI 1640 containing
10% foetal calf serum (FCS) with the following additives:
hydrocortisone (1 mg/ml), thyoglycerol (0.01 mg/ml), and insulin
(0.025 U/ml). LIM1899 stably expressing pTune/-LGR5 were
maintained in RPMI1640+Adds+10% FCS with the addition of
neomycin (G418) at a final concentration of 1.5 mg/ml. LIM1899
stably expressing non-target shRNA (NT) or shRNA to LGR5
(shLGR5) were maintained in RPMI1640+Adds+10% FCS with
the addition of hygromycin at a final concentration of 2 mg/ml.
mRNA and DNA preparation
mRNA was isolated from cells with an Illustra RNAspin Mini
RNA isolation Kit (GE Healthcare, Cat. No. 25-0500-71). To
preserve RNA stability, samples were kept frozen in a 280uC
freezer. cDNA was prepared by reverse transcription from RNA
using High-Capacity cDNA Reverse Transcription Kits (Applied
Biosystem, cat#. 4368814).
Wnt stimulation
Cells were plated in 6-well trays (for RNA preparation) or in
Lab-Tek microchamber slides (Nunc, Rochester, NY) and grown
to approximately 80% confluence. Culture medium, L-cell
conditioned medium or medium conditioned by L-cells expressing
wnt3a or wnt5a were added to parallel wells to a final
concentration of 30% (v/v). Cells were harvested at different time
points for RNA preparation or for immunofluorescence analysis.
In wnt3a titration experiments recombinant wnt3a (R&D
Systems, MN,USA) was used instead of wnt3a conditioned
medium.
Immunofluorescence
Cultured cells were plated onto LabTek microchamber slides a
minimum of three days before processing. Frozen sections (5 mm)
obtained from mouse xenografts of LIM1899 cells were air dried
on glass slides for 1 hr before processing.
All slides were fixed in 4% formaldehyde/PBS for 15 min, and
permeabilized in0.2%TritonX-100inPBSfor10 min.Nonspecific
binding sites wee blocked by incubation with 2% Bovine Serum
Albumin (BSA)inPBSfor1–3 hrat RT.Slideswereincubated with
the relevant primary antibody (1 hr at RT or overnight at 4uC),
washed three times and incubated with Alexa 488 or Alexa 546-
labelled secondary antibodies (45 min at RT). In some experiments,
rhodamine-labelled phalloidin was included with the secondary
antibody. DAPI (0.1 mg/ml; Molecular Probes) was added in the
last ten minutes of incubation. Slides were dehydrated sequentially
in Ethanol and Xylene and mounted with DPX mounting medium.
Samples were imaged with Nikon Plan Apo 606 (NA1.4) oil
immersionlensona NikonC1confocalmicroscope,.orinwide field
with a Nikon 90i fluorescent microscope. Images were obtained
using standard filter sets and laser lines.
Immunoblotting
Cells in culture wells were rinsed 16 in ice-cold PBS then
scraped directly in Cell Lysis Buffer (CLB:HEPES pH7.5 20 mM,
NaCl 150 mM, EDTA 5 mM, Triton X-100 1%v/v, Sodium
Deoxycholate 1% v/v, protease inhibitors) on ice. The lysates were
incubated for 45 min at 4uC, then centrifuged at 13,000 rpm for
30 min at 4uC. Supernatant fluids and pellets were harvested
separately. Both samples were resuspended in SDS sample buffer
and boiled for 10 min. Proteins were separated on 4–12% Bis-Tris
gradient gels (Invitrogen, Carlsbad CA) and transferred electro-
phoretically onto nitrocellulose membranes using a iBlot dry
transfer system (Invitrogen, Carlsbad, CA). The membranes were
incubated in Tris-buffered saline (TBS) containing skim milk
powder (3%w/v) for 1–3 hrs at RT to block non-sppecific binding
sites, then incubated with the appropriate antibodies for 3 hrs at
RT or 16 hrs at 4uC. Fluorescent secondary antibodies were
purchased from Li-Cor (Lincoln, NB). Immunoreactive bands
were detected using Odyssey infrared photometer (Li-Cor,
Lincoln, Nebraska) according to the manufacturer’s protocol.
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integration.
FACS analysis
Cells were harvested by trypsinization, collected in FACS buffer
(PBS containing 5%v/v FCS and 5 mM EDTA), and aliquoted in
individual tubes for antibody staining. Cells were incubated with
the appropriate first antibody for 40 min on ice, washed twice in
ice-cold PBS, then incubated with the appropriate Alexa 488-
coupled secondary antibody. Fluorescence profiles were acquired
on a BD FACSCalibur (Franklin Lakes, NJ) using the CellQuest
program.
Silencing of LGR5
siRNAs (Ambion, Austin, TX) and shRNAs (Sigma, St Louis,
MO) were used to silence LGR5 and Msi-1 expression. For
shRNA delivery, the cells were infected with lentiviral particles
encoding shRNA to Lgr5, Msi-1 or non-target as per manufac-
turer instruction. Stable cell lines were established with puromycin
selection. Cy3 labeled Lgr5-siRNA (Ambion, Cat No AM16811,
ID 139290, Austin, TX, USA) and vector control (Ambion, Cat
No. AM4624) were used for transient transfections Cells for
transfection were plated one day prior to transfection at 4610
5
cell/well in 6 well plates. For preparation of the transfection
reagent 15 mL X-tremeGENE siRNA transfection reagent were
mixed with 285 mL of serum-free Opti-MEM-1 medium, and in a
second tube 48 mL CY3 labelled LGR5-siRNA or vector control
were mixed with 252 mL OPT medium. The contents of the two
tubes were mixed and incubated for 15 minutes at room
temperature. 600 mL of mixture was added for each well in
2.5 mL medium without antibiotics and 10% FCS. The cells were
incubated at 37uC in an atmosphere of 10%CO2 for the
appropriate time (1–5 days) before harvesting.
Overexpression of LGR5
Cells were plated one day prior to the transfection experiment at
4610
5 cell/well in 6 well plates. Cells were transfected with the
pTUNE Inducible Vector without insert (vector control) or
containing the LGR5 ORF construct flanked by Flag (DDK) and
Myc sequences (OriGene, Cat. No. RT212825) using FuGENE
HD transfection Reagent (Roche, Cat. No. 04709713001). The
LGR5 construct was fully sequenced prior to use, and the sequence
proven to be correct. Transfection complex was prepared by adding
6 mg plasmid DNA in 92 mL OPT medium followed by addition of
8 mL FuGENE HD Reagent (ratio of 8:6). The mixture was
incubated at room temperature for 159,t h e n1 0 0mL of mix were
added to each well. After 72 h–120 h culture at 37uC, the cells were
harvested for protein and RNA isolation. Stable cell lines were
derived by selection in Neomycin (G418, 1.6 mg/ml). Mock-
transfected LIM1899 cells, exposed to the transfection reagent but
in the absence of DNA, were used as a control.
qRT-PCR and Superarrays
RNA was prepared form each cell line with RNeasy Plus mini
kit (Qiagen). cDNA was synthesized from 5–20 mg RNA per
sample using a high capacity cDNA reverse transcription kit
(Applied Biosystems). qRT-PCR was performed using the primers
listed in Table S7. PCRs were carried out in a reaction volume of
25 ml using Power SYBR Green PCR Master Mix (AppliedBio-
systems). GAPDH was used as internal control. The samples were
amplified in a in 7300 Real-Time PCR system (Applied Biosystem)
and data analysed with SDS software version 4.0 (Applied
Biosystem) using the DDCT method.
RT2 Profiler
TM PCR arrays (Superarrays) and qPCR Master-
Mix were purchased from SABioscience (Qiagen, Germantown,
MD, USA). Each array was performed in triplicate according to
the manufacturer’s instructions using 5 mg of cDNA per plate.
Results were analysed with ABI 7300 SDS software (Applied
Biosystems) and SaBioscience RT2 data analysis program. All
dissociation curves were checked manually, and samples with
double peaks eliminated from the analysis. Baseline and threshold
values were set manually for each detector.
Cellular assays
Proliferation (MTT). Cell proliferation was measured using
an MTT assay. Cells were counted, resuspended at 2610
3 cells
per 200 ml medium, and plated in 96-well plates for incubation at
37uC and 10%CO2 in air for up to 10 days. At the end of the
incubation, 10 ml of 5 um MTT reagent (Sigma, St Louis, MO,
USA) was added to each well, and incubated for 4 h. The plates
were centrifuged at 1500 rpm for 10 min and the medium were
removed. The MTT precipitate was solubilised by the addition of
200 ml/well acidified isopropanol, and the absorbance at 570 nm
was measured in triplicate wells.
Soft agar cloning. Cells were counted, resuspended at
2.5610
3/ml or 5610
2/ml in medium (DME with 10% FBS and
L-glutamine) containing 0.3% w/v agar (Bacto, Duckinson, Sparks
MD, USA) and overlayed onto a 30-mm dish containing a
solidified bottom layer of 0.6% w/v agar in the same medium.
After incubation for 10–15 days at 37uC and 10%CO2, all dishes
were stained by adding 1 ml/dish of 0.01%(w/v) crystal violet
(Fronine, Taren Point, NSW, Australia) and the colonies counted
with a dissecting microscope. Assays were performed in triplicate.
Spheroid cultures. Cells were trypsinized, washed in
complete medium and resuspended in RPMI+Adds with 20%
FCS at 1.66610
4 cells/ml. Culture dishes were filled with PBS;
30 ml droplets (500 cells/drop) were deposited on the up-turned
inner surface of the lid, then the lid was then inverted and placed
on top of the culture dish. The hanging drops were cultured for
up to 10 days in 37uC incubator with 10%CO2. The resulting
spheroids were photographed in phase contrast on a Nikon
Eclipse Ti microscope using a 106 l e n sa n daw i t ha
Colormetrics Coolsnap HQ ccd camera. The volume of the
spheroids was estimated using the modified ellipsoid formula (1/2
length6width
2) using 10 individual images per cell line. The
average cell number of the spheroid was measured in 10
spheroids per cell line: the spheroids were individually trypsinized
to yield single cell suspensions, and the cell number counted
using a hemocytometer.
Wound repair assays. Cells were plated in 24-well plates at
10
6 cells/well in 1 ml culture medium. Two days later a wound
was scratched in the adherent cell monolayers with an Eppendorf
tip and the medium was changed to remove loosened cells. The
wells were examined every two days and photomicrographs taken
on a Nikon Eclipse Ti as described above. Wound width was
measured on photomicrographs, using the same area of the well
for each measurement.
Transwell assays. Cell culture inserts (8 m pore size,
cat#353097, BD Falcon, Franklin Lakes NJ) were placed in 24-
well plates containing 1 ml of culture medium and the chambers
seeded with 5610
5 cells in 300 ml culture medium. Plates were
incubated for three days before changing the medium in the upper
chamber to serum-free RPMI. Cells were incubated for a further
24 h before harvesting the filters. To stain the filters, all medium
was removed from both the wells and the inserts and replaced with
1 ml of May-Grumwald reagent for 4 min. After rinsing
extensively in tap water, the filters were counterstained in
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attached to the upper side of the filters were scraped using a cotton
swab, rinsed twice and re-swabbed. Filters were excised from the
inserts and mounted on glass slides with the lower side (containing
the migrating cells) towards the glass. Cells were counted using a
light microscope with a 106lens.
Tumour Xenografts
LIM1899 cells were grown in bulk and transfected with either
pTune-LGR5 vector, control vector or Cy3-siRNA to LGR5 as
described above. Two days after transfection the cells were
collected by trypsinization, counted and injected at 5610
6 cells/
site subcutaneously on both flanks of nude mice. Tumours were
measured twice weekly with callipers. Tumour volumes were
estimated using the modified ellipsoid formula V=1/2
(length6width
2). Tumour mass was determined by weighing each
dissected tumour at the end of the experiment.
Supporting Information
Figure S1 Specificity of LGR5 staining and induction by
wnt 3a. A): HEK293T cells were transiently transfected with a
construct encoding for flag-tagged LGR5 as described in Methods.
Cells were processed for immunofluorescence and stained with
rhodamine-phallodin (red channel), DAPI (blue channel) and
commercially available antibodies to the flag tag (M2) or to LGR5
(Ap2745f and HPA012530) followed by Alexa 488 secondary
antibody (green channel), as described in Methods. Left panels:
untransfected cells; right panels: cells transfected with M2-LGR5. B):
LIM2537 and LIM1863 cells were incubated for 48 hrs with control
medium (L-cell conditioned medium) or with conditioned medium
from wnt3a-transfected L-cells. Cells were prepared for immunoflu-
orescence and stained with rhodamin-phalloidin (red channel), DAPI
(blue channel) and anti-LGR5 antibody Ap2745f followed by
Alexa488 anti-rabbit Ig (green channel).Left panels: composite image
(three channels); right panels: LGR5 staining (green channel) only. In
the same experiment, exposure to wnt 5a did not alter the levels of
LGR5 detectedableby IF. Cells were imaged on a Nikon C1 confocal
microscope using a 606 oil lens. Laser gains were set on negative
control slides (irrelevant primary antibody) and kept constant
throughout. Images were processed using EZ-C1 software.
(TIF)
Figure S2 Confocal analysis of LGR5 staining after
silencing of LGR5. LIM1215 and Lim1899 cells expressing
non-target shRNA or shRNA to LGR5 were grown in
microchamber slides and prepared for immunofluorescence as
described in Methods. Cells were stained with anti E-cadherin
antibody followed by Alexa 546 anti-mouse Ig (red), anti-LGR5
followed by Alexa 488 anti-rabbit Ig (green) and the nuclear stain
DAPI (blue). Left panels: composite image (three channels); right
panels: LGR5 staining only (channel 2, greyscale). Images were
acquired and processed as described in the legend to Fig. S1.
(TIF)
Figure S3 Cell proliferation in adherent cell cultures.
Cells expressing various constructs were tested for their ability to
proliferate under standard tissue culture conditions using the MTT
assay as described in Methods. A: LIM 1215 cells (left panel) and
LIM1899 cells (right panel) were either not transfected (parental), or
transduced with lentiviral shRNA to non-target sequences (NT),to
LGR5 (shLGR5) or to Msi-1 (shMsi-1). Cells containing the
shRNAs were selected for one week in puromycin, then switched to
normal medium for three days before assay. Specific knockdown of
LGR5 and Msi-1 was confirmed by qRT-PCR in parallel samples.
B: LIM1899 cells weremock-transfected(parental),transfectedwith
empty pTune vector (vector), or transfected with pTune vector
containing LGR5 (LGR5). Cells were grown for three days after
transfection then assayed. Overexpression of LGR5 was confirmed
by qRT-PCR on parallel samples.
(TIF)
Figure S4 Stable LGR5 overexpression in LIM1899-
derived cell lines. LIM1899 cells were transfected with
pTune/LGR5 and selected for expression of the construct in
medium containing neomycin. Stable cell lines were expanded,
switched to antibiotic-free medium and characterized for LGR5
expression and clonogenicity. A) LGR5 expression by immunofluo-
rescence: parental cells and three clonal cell lines overexpressing
LGR5 cells were fixed, permeabilized and stained with anti-flag
antibody (M2) followed by Alexa 488 anti-mouse Ig (green) and
nuclear stain DAPI (blue). Images were collected and analysed as
described in Methods. B) Expression of LGR5 in parental cells and
stable cell lines was determined by qRT-PCR. Parental LIM1899
mRNA was used as an equalizer. Data are the average and sd of
duplicate determinations. C) Clonogenicity in soft agar: cells were
seeded in soft agar plates and colony numbers determined after 10
days as described in Methods. Results arepresented as mean values of
each test sample over control (untransfected) cells. Each cell line was
tested in triplicate. Statistical significance was determined by
unpaired t-test. **=p,0.005 ***=p,0.001. D) Correlation be-
tween expression of LGR5 and loss of clonogenicity in soft agar. The
data presented in graphs B and C were plotted against each other,
and fitted using a first-order exponential decay function.
(TIF)
Figure S5 Quantitation of cellular proteins in LIM1899
with altered expression of LGR5. A) Total cellular lysates
from untransfected LIM 1899 (parental) and LIM1899 transfected
with vector (V), with siLGR5 or with pTune/LGR5(LGR5) were
analysed by SDS-PAGE and immunoblotting as described in
Methods. In some experiments, both transient (LGR5 T) and stable
(LGR5 S) transfectants of pTune/LGR5 were tested in parallel.
There was no appreciable difference in protein expression between
transient and stable LGR5 transfectants, and the results have been
pooled in the quantitative analysis. B) Quantitation of protein
expression from immunoblotting experiements. Band intensity was
quantitated by wide-line integration using ImageQuant. The relative
amount of each protein is expressed as a ratio of the specific band to
the loading control b-tubulin for each lane. The data are presented as
average and sd of at least three transfection experiments analysed on
separate gels. To make the data from each gel comparable, all ratios
have been normalized setting the value of the protein level in the
parental cell line in each experiment to 1.
(TIF)
Figure S6 Expression of CD antigens on parental and
transfected LIM1899 cells. LIM1899 cells were transfected
with Cy3 siRNA to LGR5 (siLGR5) or with pTune/LGR5 (LGR5
Tr). Three days after transfection parental cells and transfected cells
were harvested and processed for FACS analysis as detailed in
Methods. A): Histograms of fluorescence profiles of cells stained
with CD44, CD133 and CD166 antibodies. Solid purple=parental
cells; red overlay=LGR5 Tr cells; teal overlay=siLGR5 cells;
green overlay=negative antibody control. B): Median fluorescence
channel values for each sample. Data were acquired on a FACS
Calibur instrument and analysed using the CellQuest program.
(TIF)
Figure S7 CD44 distribution in LIM 1215 cells after
silencing of LGR5. LIM1215 cells were transduced with either
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seeded in chamber slides, fixed and stained with rhodamine-
phalloidin (red channel), anti-CD44 followed by Alexa 488 anti-rat
Ig (green channel) and nuclear stain DAPI (blue channel). Top
panels: composite image with three channels. Bottom panels: grey
scale image for CD44.
(TIF)
Figure S8 Wnt array. mRNA was prepared from LIM1899
untransfected, transfected with empty vector, with siLGR5 or
transfected with pTune/LGR5. Expression of genes in the wnt
pathway was determined by qRT-PCR using Superarray plates
(SABioscience). The experiments were performed and analyzed as
described in Methods. Data are the mean of three independent
experiments for each data set. ‘‘Parental’’ set includes untransfected
cells and cells transfected with empty vectors. Left panels show the
correlation in gene expression levels between parental (abscissa) and
test (ordinate) samples. Right panels show the ‘‘volcano plots’’ of
expression changes (abscissa) vs statistical significance (ordinate) The
black line indicates no change (fold change=1), the red lines indicate
t h e2 - f o l dc h a n g et h r e s h o l d ,a n dt h eb l u el i n ei nt h ev o l c a n op l o t s
indicates the p value chosen for t-test threshold. A) LGR5
overexpressors vs control cells; B) LGR5 knockdown vs control cells.
(TIF)
Figure S9 Notch array. mRNA was prepared from LIM1899
untransfected, transfected with empty vectors, with siLGR5 or with
pTune/LGR5. Expression of genes in the Notch pathway was
determined by qRT-PCR using Superarray plates (SABioscience).
The experiments were performed and analyzed as described in
Methods. Data are the mean of three independent experiments for
each data set. ‘‘parental’’ set includes untransfected cells and cells
transfected with empty vectors. Left panels show the correlation in
gene expression levels between parental (abscissa) and test (ordinate)
samples.Rightpanelsshowthe ‘‘volcanoplots’’ofexpressionchanges
(abscissa) vs statistical significance (ordinate) The black line indicates
no change (fold change=1), the red lines indicate the 2-fold change
threshold, and the blue line in the volcano plots indicates the p value
chosen for t-test threshold. A) LGR5 overexpressors vs control cells;
B) LGR5 knockdown vs control cells.
(TIF)
Figure S10 EMT array. mRNA was prepared from LIM1899
untransfected, transfected with empty vectors, with siLGR5 or
with pTune/LGR5. Expression of genes in the EMT pathway was
determined by qRT-PCR using Superarray plates (SABioscience).
The experiments were performed and analyzed as described in
Methods. Data are the mean of three independent experiments for
each data set. ‘‘parental’’ set includes untransfected cells and cells
transfected with empty vectors. Left panels show the correlation in
gene expression levels between parental (abscissa) and test (ordinate)
samples. Right panels show the ‘‘volcano plots’’ of expression
changes (abscissa) vs statistical significance (ordinate) The black line
indicates no change (fold change=1), the red lines indicate the 2-
fold change threshold, and the blue line in the volcano plots
indicates the p value chosen for t-test threshold. A) LGR5
overexpressorsvscontrolcells;B)LGR5knockdownvscontrolcells.
(TIF)
Figure S11 Colorectal cancer cell lines LIM2405 and LIM 2550
plated in 6-well trays were exposed to increasing concentrations of
recombinant wnt 3a (0, 22, 66 or 200 ng/ml) and harvested 12 or
24 hrs after addition of the stimulus. mRNA was prepared from
each well and the amount of LGR5 message quantitated by qRT-
PCR. Duplicate wells were used for each condition, and the
experiment was repeated twice. The graphs show the average and
standard deviation of duplicate experiments as fold-change in
LGR5 expression relative to the internal control (no wnt3a at 12
and 24 hr, respectively).
(TIF)
Table S1 Wnt Array. Changes in LIM1899 gene expression
with upregulation of LGR5.
(DOC)
Table S2 Wnt array. Changes in LIM1899 gene expression with
knockdown of LGR5.
(DOC)
Table S3 Notch Array. Changes in LIM1899 gene expression
with overexpression of LGR5.
(DOC)
Table S4 Notch Array. Changes in LIM1899 gene expression
with knockdown of LGR5.
(DOC)
Table S5 EMT Array. Changes in LIM1899 gene expression
with overexpression of LGR5.
(DOC)
Table S6 EMT Array. Changes in LIM1899 gene expression
with knockdown of LGR5.
(DOC)
Table S7 Primer list for quantitative real-time PCR.
(DOC)
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